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Protease Inhibitors Interfere with the
Necessary Factors of Carcinogenesis
by Walter Troll*
Many tumorpromoters are inflammatory agents thatstimulate the formation ofoxygen radicals ( O2) and
hydrogen peroxide (H202) in phagocytic neutrophils. The neutrophils use the oxygen radicals to kill bacte-
ria, which are recognized bythe cell membrane ofphagocytic cellscausing asignal to mount the oxygen re-
sponse. The tumor promoter isolated from croton oil, 12-0-tetradecanoylphorbol-13-acetate (TPA), mimics
the signal, causing an oxygen radical release that is intended to kill bacteria; instead, it injures cells in the
host. Oxygen radicals cause single strand breaks in DNAandmodify DNAbases. These damagingreactions
appear to be related to tumorpromotion, as three types ofchemopreventive agents, retinoids, onion oil, and
protease inhibitors, suppress the induction ofoxygen radicals inphagocytic neutrophils and suppress tumor
promotion in skin cancer in mice. Protease inhibitors also suppress breast and colon cancers in mice. Pro-
tease inhibitors capable ofinhibitingchymotrypsin show a greater suppression ofthe oxygen effect and are
better suppressors oftumorpromotion. In addition, oxygen radicals may be one ofthe manyagents that cause
activation ofoncogenes. Since retinoids andprotease inhibitors suppress theexpression ofthe ras oncogene
in NIH 3T3 cells, NIH3T3 cells may serve as arelatively facile model forfindingand measuringchemopreven-
tive agents that interfere with the carcinogenic process.
Frequently, the development of new concepts regard-
ingthe mechanisms ofbiological phenomena, such as the
multiple stages of carcinogenesis, requires the coopera-
tive interaction of several individuals who look at data
from different perspectives. An example is the finding
that tumor promotion by inflammatory agents is due in
part to a false signal acting on neutrophils to yield oxy-
genradicals. Thisfindingwas due to NortonNelson'sfore-
sight and leadership in bringingtogether Bernard Gold-
stein, an eminent hematologist, Gisela Witz, an organic
chemist who prepared and studied tumor promoters in
Benjamin Van Duuren's lab, and myself, abiochemist in-
terested in suppressing the action of tumor promoters.
Goldstein was experienced in measuring oxygen radicals
and hydrogen peroxide in human neutrophils caused by
the action ofinvadingbacteriainperturbingthe cell mem-
brane. Witz's experience with the inflammatory action of
tumor promoters led to the substitution ofthe bacterial
challenge with the pure tumor promoter TPA. TPA
caused the formation of * 0- and H202, which interact
with human and animal phagocytic neutrophils (1,2). The
role ofoxygen radicals in tumorpromotion received some
support from the observation that agents known to sup-
press tumorpromotion are also effective inhibitors ofthe
formation of oxygen radicals. These include the anti-
inflammatory hormone dexamethasone, onion oil compo-
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nentsblockinglipoxygenase, retinoids, andprotease inhi-
bitors (3-5).
Protease inhibitors were a novel entry into the group
of agents that suppress the oxygen response of phago-
cytes. We noted the suppression ofH202 in fertilized sea
urchin eggs by soybean and other trypsin inhibitors and
the resulting polyspermy. Fertilization by the first suc-
cessful sperm induces the oxidation response, which
results in the excretion of H202 that kills excess sperm.
Protease inhibitors suppress the formation ofH202, per-
mitting the excess sperm to survive and causing poly-
spermy. Catalase, the enzyme that specifically destroys
H202, also causes polyspermy. Protease inhibitors sup-
press the induction of H202 in the sea urchin egg (6,7).
Protease inhibitors suppressH202formationinducedby
TPA in phagocytic neutrophils. The inhibitors of
chymotrypsin appeared to be more effective than those
of trypsin in suppressing oxygen radical and hydrogen
peroxide formation by human neutrophils. Thus the
Bowman-Birk soybean inhibitor, which is a more power-
ful inhibitor ofchymotrypsin than the Kunitz soybean in-
hibitor, showed a 7-fold greater suppression of *0 2 pro-
duction by TPA in neutrophils than the Kunitz inhibitor
(8). In a more extended experiment, studying H202 for-
mationbyTPA-induced neutrophils, H202 formation was
increasingly blocked by a series ofprotease inhibitors de-
pending on their potency to inhibit chymotrypsin. The
most powerful inhibitor is the potato inhibitor 1 (PT1),
which exclusively inhibits chymotrypsin.W TROLL
The order ofactivity ofsuppression ofH202 formation
is shown in Figure 1 and Table 1, taken from the recent
publication of Frenkel et al. (9). We see that the PT1,
which only forms a tight complex with chymotrypsin and
is without activity in blocking trypsin at a 10 ,uM concen-
tration, blocks hydrogen peroxide formation by 88%. The
mechanism ofthis almost total suppression ofthe oxygen
burst by this chymotrypsin inhibitor remains to be eluci-
dated. It is not due to the inhibition ofsuperoxide dismu-
tase (SOD) (10), the enzyme which converts * 0- to H202,
since it is not overcome by adding an excess of this en-
zyme (Thble 1). PT1, an exclusive chymotrypsin inhibitor,
shows sharply ascending curves of H202 suppression at
levels of 1 to 10 ,uM. The potato inhibitor 2 (PT2), which
has prosthetic groups inhibiting both trypsin and
chymotrypsin, suppressed H202 to a lesser extent (39%
at 10 ,M versus 88% by PT1), and the suppression
plateaus at higher concentrations only reached 70% sup-
pression at 40 ,uM (Fig. 1, Table 1). Moreover, the
chymotrypsin inhibitor fraction isolated from PT2 is a
more effective suppressor of H202 formation than PT2,
containing a trypsin inhibition capacity as well (Fig. 2).
This unusual property ofthe chymotrypsin inhibitor may
be responsible for its more effective action in blocking in
vivo and in vitro tumor promotion. Thus, the synthetic
chymotrypsin inhibitor, tosyl-phenylalanine-chloromethyl
ketone, was more effective than the analogous trypsin in-
hibitor, tosyl-L-lysine chloromethyl ketone, in blocking tu-
mor promotion (11). The chymotrypsin prosthetic group
ofthe Bowman-Birk soybean inhibitor, which is similar to
the PT2 trypsin and chymotrypsin combining groups, was
identified as the important constituent responsible for
suppressing neoplastic transformation caused by ionizing
radiation in C3H/1OT/2 cells (12). Indeed, Yavelow et al.
have identified a chymotrypsin-type enzyme in the cell
membrane of 10T/2 cells, which may act as a receptor for
the localization of protease inhibitors with inhibitory
properties to chymotrypsin (13). The chymotrypsin inhib-
itor PT1 also inhibits radiation induced neoplastic trans-
formation of C3H/10T/2 cells (14).
On the other hand, trypsin inhibitors also have anticar-
cinogenic properties, as shown by the observation that
6-amino caproic acid, a trypsin and plasminogen activa-
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FIGURE 1. Protease inhibitor-induced decrease of H202 formation by
TPA-activated human PMNs. PMNs (7.5-8.5 x 104) were treated with
various concentrations (1.25-100 pM) ofprotease inhibitorsjust prior
to activation with TPA(25 nM), incubated with phenol red and horse-
radish peroxidase at 370C for 30 min, and absorbance was determined
at 590 nm. Protease inhibitors used were: PtI-1 (---0), PtI-2 (A----A),
PCI (A A), COI (- ---), TOOI (O-- -LO), BBI (X-X), LBI (e- *)
and SBTI (O---O). Representative experiments (9).
tor inhibitor without any inhibitory action against
chymotrypsin, suppresses chemically induced colon can-
cer in mice (15). This inhibitor, in common with all pro-
tease inhibitors, will limit the digestion of proteins to
amino acids, which decreases the availability of amino
acids to the growing cancer cell (16). This simple com-
pound, which is closely related to the nutritionally essen-
Table 1. Percentage inhibition ofH202 formation by TPA-activated PMNs caused by protease inhibitors (9).a,b
Concentration
of PIs PTI-1c PTI-2c PCI-2c COIC TOOIc BBIc SBTIc
1.25 - 2.5 (1) 13.7 (1) - - - -
2.5 29.5 (1) 20.0 (1) 31.4 + 1.0(2) - - - -
5.0 40.5 + 1.0(2) 32.0 + 1.0(2) 37.9 + 0.7(4) 16.9 (1) 0.4 (1) - -
7.5 58.6 (1) - - - - - -
10 87.5 + 1.0(2) 37.6 + 1.3(4) 42.1 + 0.5(2) 23.6 + 0.1(2) 21.7 (1) - 0.3 (1)
20 - 47.7 + 4.7(2) 44.2 + 0.1(2) 29.7 + 5.9(3) 19.5 + 1.7(2) - 7.0 + 1.3(2)
25 - - - - - 22.5 1.8(2) -
40 - 63.8 + 6.4(2) - 40.3 ± 8.0(2) 26.8 (1) - 13.9 + 2.7(3)
50 - - 37.8 (1) -
80 - - - - - - 17.2 (1)
aIncubation at 370C for 30 min.
bNumbers in parentheses show how many PMN concentrations were assayed.
CAbbreviations: PTI-1, potato inhibitor 1; PTI-2, potato inhibitor 2; PCI-2, chymotrypsin-inhibitory fragment of PTI-2; COI, chicken ovoinhibitor;
TOOI, turkey ovomucoid ovoinhibitor; BBI, Bowman-Birk inhibitor from soybeans; SBTI, soybean (Kunitz) trypsin inhibitor.
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FIGURE 2. Time course of H202 formation by TPA-activated PMNs in
the absence(O---0; no PI) orpresence ofprotease inhibitors(represen-
tative experiments). PMNs (8 x 104) were treated with 5 MM PCI-2
(A... A) or 10IM PtI-2(A----A)justbefore addition ofTPA(25nM).
Samples were incubated at 370C for 10 to 60 min and absorbance was
determined at 590 nm (9)
tial amino acidlysine, doesnotblockH202formation from
neutrophils but rather appears to inhibitthe induction of
the DNA polymerase a, an important enzyme foramplifi-
cation ofvirus-modified DNA (17). Garte et al. have re-
cently shown that 6-amino caproic acid, al-trypsin inhib-
itor and leupeptin suppress the expression of ras
oncogene modification of NIH 3T3 cells (18).
Thus, there appeartobe multiple mechanisms by which
protease inhibitors and other chemopreventive agents in-
terfere with the development ofcancer. The role ofoxy-
gen radicals in relation to oncogene activation ofexpres-
sion of oncogenes needs to be investigated. The recent
workby Sawey et al. showed that ionizing radiation that
causes tumors on rat skin also induces specific oncogenes
(19). Asionizingradiation causestheformation ofoxygen
radicals, theymaybe responsible forthe activation ofon-
cogenes (19). The mechanisms ofthe chemopreventive ac-
tion ofretinoids, includingtheirblockingoftumorpromo-
tionandexperimental breast cancer, may alsobe related
to their antioxidant properties, as shown by their block-
ing of oxygen radical formation in TPA-induced neu-
trophils (1, 2). It is ofinterest that all trans-retinoic acid
hasrecentlybeen shown to blockras oncogene expression
in NIH 3T3 cells (S. J. Garte, personal communication).
Thus, protease inhibitors and retinoids, chemopreven-
tive agents ofdifferent types, suppress oncogene expres-
sion. This suggests that the technique of studying on-
cogene expression may serve as a facile assay for
identifying and measuring chemopreventive agents. It is
less costly and requires less time than the conventional
methods of causing animal cancer by a carcinogen and
preventing itby presumptive chemopreventive agents ap-
plied to the tissue orin the food ofthe experimental ani-
mal. The suppression ofoncogene expression, as shown
by the decreased number oftransformed NIH 3T3 cells
caused by an oncogene, takes 19 days and offers the op-
portunity of studying many potential anticarcinogens.
Protease inhibitors interfere with carcinogenesis by
multiple mechanisms, including suppression of oxygen
radicalformation byneutrophils, suppression ofinduction
ofDNApolymerase, and decreasingacids available to the
growing cancercell. Theiruse asanticarcinogenic agents
in man requires investigation.
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